The subcutaneous formulation developed using Halozyme's Enhanze drug delivery technology will therefore be indicated in Europe with J&J’s (NYSE:JNJ) cancer medicine Lazcluze as a first-line ...

Biological targets represent a considerable test of our knowledge of the fundamental principles of molecular recognition. Effective modulation of biological events requires the generation of molecules ...

As for its tolerability, based on 52 patients, J&J (NYSE:JNJ) said that TAR-200 indicated a safety profile consistent with prior findings, and there were no new safety signals. However ...

Biochemistry & Molecular Genetics Home Faculty Edwards, Yvonne J.K., Ph.D. Faculty Edwards, Yvonne J.K., Ph.D. Dr. Edwards holds a Ph.D. and an M.S. in Bioinformatics ...

Partridge, S. M., and Westall, R. G., Biochem. J., 44, 418 (1949).